Distinct clinical, laboratory and molecular features of myeloproliferative neoplasm patients with splanchnic vein thrombosis

Br J Haematol. 2018 Oct;183(2):310-313. doi: 10.1111/bjh.14958. Epub 2017 Oct 19.

Authors

Joan How¹, Kathryn M Trinkaus², Stephen T Oh¹

Affiliations

¹ Division of Hematology, Washington University School of Medicine, St. Louis, MO, USA.
² Biostatistics Shared Resource, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.

PMID: 29048104
DOI: 10.1111/bjh.14958

No abstract available

Keywords: essential thrombocythaemia; myeloproliferative neoplasm; polycythaemia vera; primary myelofibrosis; splanchnic vein thrombosis.

MeSH terms

Aged
Case-Control Studies
Female
Gene Frequency
Humans
Janus Kinase 2 / genetics
Male
Middle Aged
Myeloproliferative Disorders / complications*
Myeloproliferative Disorders / genetics
Splanchnic Circulation*
Venous Thrombosis / etiology*
Venous Thrombosis / genetics

Substances

JAK2 protein, human
Janus Kinase 2